These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 3104394)

  • 1. Steroid profiles during cycles with HCG stimulation of luteal function during in-vitro fertilization cycles.
    Blacker C; Cohen J; Castanier M; Debache C; Mandelbaum J; Plachot M; Scholler R
    Hum Reprod; 1986 Feb; 1(2):69-73. PubMed ID: 3104394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human chorionic gonadotrophin is a better luteal support than progesterone in ultrashort gonadotrophin-releasing hormone agonist/menotrophin in-vitro fertilization cycles.
    Golan A; Herman A; Soffer Y; Bukovsky I; Caspi E; Ron-El R
    Hum Reprod; 1993 Sep; 8(9):1372-5. PubMed ID: 8253920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequential use of clomiphene citrate, human menopausal gonadotropin, and human chorionic gonadotropin in human in vitro fertilization. II. Study of luteal phase adequacy following aspiration of the preovulatory follicles.
    Cohen JJ; Debache C; Pigeau F; Mandelbaum J; Plachot M; de Brux J
    Fertil Steril; 1984 Sep; 42(3):360-5. PubMed ID: 6432585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of gonadotrophin-releasing hormone agonists administered as desensitizing or flare protocols on hormonal function in the luteal phase of hyperstimulated cycles.
    Norman RJ; Warnes GM; Wang X; Kirby CA; Matthews CD
    Hum Reprod; 1991 Feb; 6(2):206-13. PubMed ID: 1905309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Luteal phase support with hCG does not improve fecundity rate in human menopausal gonadotropin-stimulated cycles.
    Keenan JA; Moghissi KS
    Obstet Gynecol; 1992 Jun; 79(6):983-7. PubMed ID: 1579327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered follicular development in clomiphene citrate versus human menopausal gonadotropin-stimulated cycles for in vitro fertilization.
    Dlugi AM; Laufer N; Botero-Ruiz W; DeCherney AH; Polan ML; Haseltine FP; Mezer HC; Behrman HR
    Fertil Steril; 1985 Jan; 43(1):40-7. PubMed ID: 3155509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Luteal phase support in in-vitro fertilization using gonadotrophin releasing hormone analogue before ovarian stimulation: a prospective randomized study of human chorionic gonadotrophin versus intramuscular progesterone.
    Claman P; Domingo M; Leader A
    Hum Reprod; 1992 Apr; 7(4):487-9. PubMed ID: 1522190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Luteal function following ovarian stimulation in rhesus monkeys for in vitro fertilization: atypical response to human chorionic gonadotropin treatment simulating early pregnancy.
    VandeVoort CA; Hess DL; Stouffer RL
    Fertil Steril; 1988 Jun; 49(6):1071-5. PubMed ID: 3131158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delaying human chorionic gonadotropin administration in human menopausal gonadotropin-induced cycles decreases successful in vitro fertilization of human oocytes.
    Laufer N; DeCherney AH; Tarlatzis BC; Zuckerman AL; Polan ML; Dlugi AM; Graebe R; Barnea ER; Naftolin F
    Fertil Steril; 1984 Aug; 42(2):198-203. PubMed ID: 6430722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progesterone alone versus progesterone combined with HCG as luteal support in GnRHa/HMG induced IVF cycles: a randomized clinical trial.
    Mochtar MH; Hogerzeil HV; Mol BW
    Hum Reprod; 1996 Aug; 11(8):1602-5. PubMed ID: 8921100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of progesterone/estradiol ratio on luteal function for achieving pregnancy in gonadotropin therapy.
    Kamada S; Kubota T; Aso T
    Horm Res; 1992; 37 Suppl 1():59-63. PubMed ID: 1427631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Luteal phase defects in assisted reproduction: the role of luteal phase supplementation.
    Capitanio GL; Ubaldi F; Giannini P; Croce S
    Acta Eur Fertil; 1992; 23(1):15-9. PubMed ID: 1293894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormonal profiles in the follicular phase, luteal phase and first trimester of pregnancies arising from in-vitro fertilization.
    Yovich JL; Stanger JD; Yovich JM; Tuvik AI; Turner SR
    Br J Obstet Gynaecol; 1985 Apr; 92(4):374-84. PubMed ID: 2580551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of low dose hCG for luteal support after triggering ovulation with a GnRH agonist in cases of polyfollicular development.
    Krause BT; Ohlinger R
    Eur J Obstet Gynecol Reprod Biol; 2006 May; 126(1):87-92. PubMed ID: 16377065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Daily low-dose hCG stimulation during the luteal phase combined with GnRHa triggered IVF cycles without exogenous progesterone: a proof of concept trial.
    Andersen CY; Elbaek HO; Alsbjerg B; Laursen RJ; Povlsen BB; Thomsen L; Humaidan P
    Hum Reprod; 2015 Oct; 30(10):2387-95. PubMed ID: 26209535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment.
    Beckers NG; Macklon NS; Eijkemans MJ; Ludwig M; Felberbaum RE; Diedrich K; Bustion S; Loumaye E; Fauser BC
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4186-92. PubMed ID: 12970285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hormone profile and follicle development in ovarian stimulation treatment for in vitro fertilization. II. Prolactin, estradiol and progesterone profile].
    Sudik R; Fliess FR; Kunkel S
    Zentralbl Gynakol; 1989; 111(9):567-80. PubMed ID: 2500795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endocrine changes in the late-follicular and postovulatory intervals as determinants of the in vitro fertilization pregnancy rate.
    Zarutskie PW; Kuzan FB; Dixon L; Soules MR
    Fertil Steril; 1987 Jan; 47(1):137-43. PubMed ID: 3098584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shortened luteal phase after ovulation induction with human menopausal gonadotropin and human chorionic gonadotropin.
    Olson JL; Rebar RW; Schreiber JR; Vaitukaitis JL
    Fertil Steril; 1983 Mar; 39(3):284-91. PubMed ID: 6402386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Gonadotrophin induction of ovulation monitored by ultrasonic studies of the ovary].
    van Schouwenburg JA
    S Afr Med J; 1985 May; 67(19):754-8. PubMed ID: 3922064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.